Literature DB >> 12592627

Keratinocyte growth factor decreases total parenteral nutrition-induced apoptosis in mouse intestinal epithelium via Bcl-2.

Barbara E Wildhaber1, Hua Yang, Daniel H Teitelbaum.   

Abstract

BACKGROUND/
PURPOSE: Total parenteral nutrition (TPN) induces epithelial cell (EC) apoptosis. Keratinocyte Growth Factor (KGF) increases EC-growth; however, little is known of its effect on apoptosis. This study aims to determine if mRNA expression of Bcl-2 proteins (major mediators of epithelial cell apoptosis) is altered with TPN, and if KGF-administration influences Bcl-2 family expression.
METHODS: C57BL/6J mice (n = 6 per group) received oral feeding (control), TPN (TPN), or TPN plus intravenous KGF daily (TPN + KGF). After 7 days, intestine was harvested and EC isolated. Apoptosis was identified using flow cytometry. EC mRNA expression of Bcl-2 family members was measured by reverse transcriptase polymerase chain reaction; Bcl-2 protein level was measured by immunoblot analysis.
RESULTS: EC apoptotic rates were: control, 14.4% +/- 5.1%; TPN, 29.4% +/- 11.3%; KGF, 17.2% +/- 5.6%. Pro-apoptotic Bcl-2 proteins changed minimally with TPN or KGF; however, the antiapoptotic protein Bcl-2 changed significantly: control, 0.78 +/- 0.24; TPN, 0.10 +/- 0.13; KGF, 0.76 +/- 0.36. EC Bcl-2 protein levels were: control, 0.16 +/- 0.13; TPN 0.18 +/- 0.16; and TPN + KGF 0.47 +/- 0.19.
CONCLUSIONS: TPN-induced apoptosis decreased Bcl-2 mRNA expression. KGF decreased EC apoptosis and increased Bcl-2 expression. Modalities to increase endogenous KGF, or KGF-administration may have benefit in patients on TPN. Copyright 2003, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12592627     DOI: 10.1053/jpsu.2003.50018

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  9 in total

Review 1.  Can we protect the gut in critical illness? The role of growth factors and other novel approaches.

Authors:  Jessica A Dominguez; Craig M Coopersmith
Journal:  Crit Care Clin       Date:  2010-07       Impact factor: 3.598

2.  Dentofacial parameters explaining variability in retroclination of the maxillary central incisors.

Authors:  Bernd G Lapatki; Andreas Klatt; Jürgen Schulte-Mönting; Irmtrud E Jonas
Journal:  J Orofac Orthop       Date:  2007-03       Impact factor: 1.938

Review 3.  Novel agents in the treatment of intestinal failure: humoral factors.

Authors:  Hua Yang; Daniel H Teitelbaum
Journal:  Gastroenterology       Date:  2006-02       Impact factor: 22.682

Review 4.  Radioprotection of normal tissue cells.

Authors:  Patrick Maier; Frederik Wenz; Carsten Herskind
Journal:  Strahlenther Onkol       Date:  2014-03-18       Impact factor: 3.621

Review 5.  Animal models of gastrointestinal and liver diseases. Animal models of infant short bowel syndrome: translational relevance and challenges.

Authors:  Per T Sangild; Denise M Ney; David L Sigalet; Andreas Vegge; Douglas Burrin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-10-23       Impact factor: 4.052

6.  Carcinoma-associated fibroblasts promotes the proliferation of a lingual carcinoma cell line by secreting keratinocyte growth factor.

Authors:  Jingwen Lin; Chuanxia Liu; Lin Ge; Qinghong Gao; Xin He; Ying Liu; Shengfu Li; Min Zhou; Qianming Chen; Hongmei Zhou
Journal:  Tumour Biol       Date:  2011-02-22

7.  Glutamine attenuates TPN-associated liver injury in infant rabbits.

Authors:  Jiang Wu; Li Hong; Wei Cai; Qingya Tang; Chenren Shi
Journal:  Eur J Pediatr       Date:  2006-11-14       Impact factor: 3.183

Review 8.  The role of growth factors in intestinal regeneration and repair in necrotizing enterocolitis.

Authors:  Kathryn J Rowland; Pamela M Choi; Brad W Warner
Journal:  Semin Pediatr Surg       Date:  2013-05       Impact factor: 2.754

Review 9.  Palifermin for the protection and regeneration of epithelial tissues following injury: new findings in basic research and pre-clinical models.

Authors:  Paul W Finch; Lawrence J Mark Cross; Daniel F McAuley; Catherine L Farrell
Journal:  J Cell Mol Med       Date:  2013-09       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.